1. Home
  2. IBKR vs NTRA Comparison

IBKR vs NTRA Comparison

Compare IBKR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBKR
  • NTRA
  • Stock Information
  • Founded
  • IBKR 1977
  • NTRA 2003
  • Country
  • IBKR United States
  • NTRA United States
  • Employees
  • IBKR N/A
  • NTRA N/A
  • Industry
  • IBKR Investment Bankers/Brokers/Service
  • NTRA Medical Specialities
  • Sector
  • IBKR Finance
  • NTRA Health Care
  • Exchange
  • IBKR Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • IBKR 22.5B
  • NTRA 21.7B
  • IPO Year
  • IBKR 2007
  • NTRA 2015
  • Fundamental
  • Price
  • IBKR $64.29
  • NTRA $178.23
  • Analyst Decision
  • IBKR Strong Buy
  • NTRA Strong Buy
  • Analyst Count
  • IBKR 8
  • NTRA 16
  • Target Price
  • IBKR $57.72
  • NTRA $193.50
  • AVG Volume (30 Days)
  • IBKR 10.3M
  • NTRA 914.8K
  • Earning Date
  • IBKR 10-14-2025
  • NTRA 11-11-2025
  • Dividend Yield
  • IBKR 0.51%
  • NTRA N/A
  • EPS Growth
  • IBKR 20.30
  • NTRA N/A
  • EPS
  • IBKR 1.90
  • NTRA N/A
  • Revenue
  • IBKR $5,637,000,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • IBKR $14.71
  • NTRA $23.93
  • Revenue Next Year
  • IBKR $6.81
  • NTRA $15.60
  • P/E Ratio
  • IBKR $32.76
  • NTRA N/A
  • Revenue Growth
  • IBKR 18.30
  • NTRA 44.38
  • 52 Week Low
  • IBKR $32.13
  • NTRA $117.27
  • 52 Week High
  • IBKR $68.07
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • IBKR 57.15
  • NTRA 65.49
  • Support Level
  • IBKR $61.26
  • NTRA $167.00
  • Resistance Level
  • IBKR $64.43
  • NTRA $176.82
  • Average True Range (ATR)
  • IBKR 1.74
  • NTRA 4.91
  • MACD
  • IBKR 0.06
  • NTRA 0.35
  • Stochastic Oscillator
  • IBKR 95.45
  • NTRA 97.67

About IBKR Interactive Brokers Group Inc.

Interactive Brokers is a large, automated, retail and institutional brokerage that boasted nearly $570 billion in customer equity at the end of 2024. The company cut its teeth as a market maker, introducing US financial markets to automated and algorithmic training before expanding into brokerage services in 1993. The firm has a wide-ranging client base, with its best-in-class order execution and extremely low margin lending rates catering to a sophisticated audience of hedge funds, proprietary traders, and introducing brokers that account for about 45% of the firm's commissions. With operations spanning more than 160 electronic exchanges, 36 countries, and 28 currencies, Interactive Brokers caters to a global clientele, with more than 80% of active accounts sitting outside the US market.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: